Desulfovibrio, a kind of sulphate-reducing bacteria, is enriched in gastric cancer patients and its metabolite (hydrogen sulphide) induces the production of NO and IL-1β to promote inflammation [49]. The gene discussed is IL1B; the disease is gastric cancer.